首页 | 官方网站   微博 | 高级检索  
     

多西他赛联合顺铂、氟尿嘧啶方案诱导化疗局部晚期鼻咽癌近期临床观察
引用本文:叶建明,王春丽,黄莉,许明君,王祥财.多西他赛联合顺铂、氟尿嘧啶方案诱导化疗局部晚期鼻咽癌近期临床观察[J].赣南医学院学报,2014(6):880-882.
作者姓名:叶建明  王春丽  黄莉  许明君  王祥财
作者单位:赣南医学院第一附属医院肿瘤科,江西 赣州,341000
摘    要:目的:评价多西他赛联合顺铂和氟尿嘧啶方案(DPF方案)诱导化疗局部晚期鼻咽癌的近期临床疗效和毒性反应。方法:对25例经病理学证实的Ⅲ、Ⅳa期初治鼻咽癌患者于第1天静脉滴注多西他赛75 mg·m-2和顺铂75 mg·m-2,氟尿嘧啶2.5 g·m-2持续静脉泵入120 h,每3周为1疗程,2疗程后行同期放化疗。同期化疗方案为顺铂40 mg·m-2每周一次。结果:25例患者中,诱导化疗后鼻咽原发灶CR 5例(20.0%)、PR 18例(72.0%)、SD2例(8.0%),总有效率为92%;颈部转移灶CR 4例(16.0%)、PR 21例(84.0%),总有效率为100%。放化疗后CR 24例(96%)、PR 1例(4%)。毒性反应主要为骨髓抑制、口腔粘膜和胃肠道反应,Ⅲ∽Ⅳ度粒细胞减少占56%,60%以上的患者出现了中度(Ⅱ、Ⅲ度)胃肠道反应,其它毒副反应少见。综合治疗完成后有1例患者出现颈部淋巴结残留,其余患者均达CR。结论:多西他赛、顺铂及5-氟尿嘧啶诱导化疗较PF方案提高了局部晚期鼻咽癌的近期疗效,而且不良反应可以接受。其近期有效率的提高是否能转化为远期疗效值得进一步研究。

关 键 词:多西他赛  顺铂  氟尿嘧啶  诱导化疗  局部晚期鼻咽癌

Observaion on Short-term Clinical Effect of Docetaxel Combined with Cisplatin and Fluorouracil for induction chemotherapy in patients with Locally Advanced Nasopharyngeal Carcinoma
YE Jian-ming,WANG Chun-li,HUANG Li,XU Ming-jun,WANG Xiang-cai.Observaion on Short-term Clinical Effect of Docetaxel Combined with Cisplatin and Fluorouracil for induction chemotherapy in patients with Locally Advanced Nasopharyngeal Carcinoma[J].Journal of Gannan Medical College,2014(6):880-882.
Authors:YE Jian-ming  WANG Chun-li  HUANG Li  XU Ming-jun  WANG Xiang-cai
Affiliation:(Dept. of Oncology, the First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000)
Abstract:Objective: To evaluate the clinical effect and toxic reaction of docetaxel combined with cisplatin and fluorouracil for induction chemotherapy in the treatment of patients with locally advanced nasopharyngeal carcinoma. Methods:Twenty-five patients with locally advanced nasopharyngeal carcinoma diagnosed pathologically were injected docetaxel( 75mg·m- 2) and cisplatin( 75 mg·m- 2) on the first day they were enrolled in by intravenous dripping; fluorouracil( 2. 5 g·m- 2) in 120 hours by continuous intravenous pumping for 2 courses with a course of 3 weeks. Concurrent chemotherapy was received. Cisplatin( 40 mg·m- 2) was injected once a week in the concurrent chemotherapy regimens. Results: Of all the 25 patients,completed response( CR) of nasopharyngeal primary tumor was 5 cases( 20. 0%),partial responses( PR) was 18 cases( 72. 0%),stable disease( SD) was 2 cases( 8. 0%),and overall response rate was96. 0%; completed response( CR) of neck metastasis lymph node was 4 cases( 16. 0%),partial responses( PR) was 21cases( 84. 0%),and overall response rate was 100. 0%. The main toxicity was myelosuppression and gastrointestinal reactions,Ⅲ ∽ Ⅳ leucopenia occurred in 56. 0% of all cases,and Ⅱ ∽ Ⅲ gastrointestinal reactions occurred more than60%,It was rare to have other side effects. After Comprehensive treatment,all the cases got to CR except one case with neck lymph node residues. Conclutions: Compared with PF regimen,The docetaxel combined with cisplatin and fluorouracil regimen increases short-term clinical effect of locally advanced nasopharyngeal carcinoma; the toxicity and side effects are well-tolerated. It is worthy of further clinical studies on whether its increased short-term effects could turn into longterm effects.
Keywords:docetaxel  cisplatin  fluorouracil  induction chemotherapy  locally advanced nasopharyngeal carcinoma
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号